Population
52,039 adults ≥40 years of age who received a new antihypertensive medication between 1994-2002 in…
Design
Cohort
Follow-up
1 year
Authors
Loading...
Early discontinuation may drive much antihypertensive nonadherence; leaves open optimal intervention timing for prospective trials.
A substantial proportion of nonadherence to antihypertensive medications is driven by patients discontinuing therapy after a single dispensation, highlighting a critical early window for intervention.
Evans et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: